BEIJING -- Recalled ibuprofen products made by pharmaceutical giant Johnson & Johnson have not been sold in China, the country's drug safety watchdog said Thursday.

China has not imported any of the recalled batches, the China Food and Drug Administration said in a statement on its website.

All Johnson & Johnson ibuprofen products in the Chinese market are made in Shanghai and the raw material suppliers were Chinese companies, the CFDA says.

The statement came after the company reported to Chinese authorities that it has recalled batches of an ibuprofen product in the United States due to quality problems.

J&J is recalling 200,000 bottles of Infant Motrin formula, which is commonly used to reduce fever and treat pain in infants, due to potential contamination by plastic particles.

The company believed the particles came from a third-party supplier of ibuprofen. Ibuprofen is an ingredient in the formula.

The CFDA has asked J&J to strengthen quality management and adverse drug reaction monitoring and ensure product quality.

It is the second time the Chinese government has urged J&J to strengthen quality management in three months.

In June, the CFDA asked the company to improve quality management after it found that the company had issued 33 recall orders since 2009.